Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and sitagliptin for impaired glucose tolerance after TIA or minor ischemic stroke
NL-OMON44685Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin and sitagliptin in prediabetes (3 arms), sponsored by Erasmus MC. Primary endpoints: Tolerability of metformin and sitagliptin, Safety of treatment and 1 more. Started Jun 2014; status: recruiting.
02
Drugs
metforminsitagliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NL-OMON44685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44685.